Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hermansky–Pudlak syndrome 3 protein (HPS3) is a component of the biogenesis of lysosome-related organelles complex-2 (BLOC-2), which mediates sorting and trafficking of proteins necessary for the proper formation of lysosome-related organelles (LROs) such as melanosomes in pigment cells and dense granules in platelets. Mutations in the HPS3 gene result in Hermansky–Pudlak syndrome type 3, a disorder characterized by oculocutaneous albinism and a bleeding diathesis due to defective LRO biogenesis and abnormal organelle function in affected cell types.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hermansky–Pudlak syndrome 3 protein (HPS3).